JASON KJONO: Open Payments
NPI 1427199009 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 74 payments from 14 companies in 2025. Trend: 2023 $4,853 · 2024 $3,416 · 2025 $1,693
Food & beverage: $1,516Education: $177
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $295 |
| GlaxoSmithKline, LLC. | 16 | $245 |
| Actelion Pharmaceuticals US, Inc. | 9 | $244 |
| GENZYME CORPORATION | 10 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $142 |
| Insmed, Inc. | 4 | $123 |
| Viatris Specialty LLC | 4 | $99 |
| SANOFI-AVENTIS U.S. LLC | 1 | $98 |
| Genentech USA, Inc. | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
Products named: DUPIXENT, NUCALA, OPSUMIT, Arikayce, FASENRA, JASCAYD, Xolair, BREZTRI.
Industry payments across MT — which companies pay providers there.
